UCSF, UC Berkeley Scientists Join Forces in New Glenn Center for Aging Research
Researchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
University of California San Francisco
Give to UCSFResearchers at UC San Francisco and UC Berkeley have teamed up to create an innovative, integrated center for research on neurodegenerative diseases.
Researchers at UCSF and Rush University Medical Center, Chicago, may have found a predictor for a disorder affecting kidney transplant recipients that can accelerate organ failure.
Bacteria that normally live in and upon us have genetic blueprints that enable them to make thousands of molecules that act like drugs, and some of these molecules might serve as the basis for new human therapeutics, according to UCSF researchers.
How much does that fitness wristband or sleep app really tell you about your health? From a medical perspective, not much. That's about to change.
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
Nobel Prize winner Stanley Prusiner is closing in on better treatments for Alzheimer's, Parkinson's and other brain diseases, and an unlikely new partnership will get him there faster.
Daiichi Sankyo and UCSF have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.
Scientists at the Gladstone Institutes and UCSF have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish.
Samsung Electronics Co., Ltd., and UC San Francisco have announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
Geneticists from Ohio, California and Japan used stem cells to correct a defective “ring chromosome” with a normal chromosome. Such therapy has the promise to correct chromosome abnormalities that give rise to birth defects, mental disabilities and growth limitations.
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
UC San Francisco’s Health eHeart Study – an ambitious technology-based cardiovascular research study – has garnered the support from the American Heart Association, the largest U.S. non-profit organization dedicated to reducing disability and deaths caused by cardiovascular disease and stroke.
Technology and health care often go hand in hand, and UC San Francisco highlighted this budding alliance at the 11th annual Dreamforce conference, hosted by cloud computing giant Salesforce.com.
Top thinkers gather at UCSF to help make the new field a reality.